• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环丙沙星控释基质系统的制剂与评价

Formulation and evaluation of controlled-release matrix systems of ciprofloxacin.

作者信息

Malipeddi Venkata Ramana, Awasthi Rajendra, Dua Kamal

机构信息

Amity Institute of Pharmacy, Amity University, Lucknow, India.

NKBR College of Pharmacy & Research Centre, Phaphunda, India.

出版信息

Polim Med. 2017 Jul-Dec;47(2):101-106. doi: 10.17219/pim/90020.

DOI:10.17219/pim/90020
PMID:30009587
Abstract

BACKGROUND

Ciprofloxacin is a broad-spectrum fluoroquinolone antibacterial drug to which most Gram-negative and many Gram-positive bacteria are highly susceptible. Fluoroquinolones are administered repeatedly, twice a day for 5 days, during the course of therapy. Hence, they require repeated administration. Ciprofloxacin qualifies as a drug candidate for a controlled-release drug delivery system.

OBJECTIVES

The present work was aimed to develop ciprofloxacin hydrochloride-containing matrix tablets by the wet granulation method.

MATERIAL AND METHODS

The tablets were prepared using EthocelTM 100 Premium and Eudragit® RS PO (Evonik Laboratory, Mumbai, India) as a rate-controlling polymer. Granular dioctyl phthalate (DCP) was used as a diluent. An isopropyl alcohol and dichloromethane (1:1) mixture was used as a granulating agent. The effect of the formulation variables on tablet performance was examined based on weight variation, hardness, friability, thickness, and drug release profiles. The results suggested that the tablets had good integrity.

RESULTS

The tablets were stable for 18 months. Formulation F7 gave a linear release pattern up to 12 h. The release of ciprofloxacin from formulation F7 followed zero-order kinetics. The release mechanism was found to be diffusion-controlled as the Higuchi equation was obeyed.

CONCLUSIONS

Ciprofloxacin hydrochloride-containing matrix tablets were prepared successfully. The tablets had good integrity and were found stable for 18 months.

摘要

背景

环丙沙星是一种广谱氟喹诺酮类抗菌药物,大多数革兰氏阴性菌和许多革兰氏阳性菌对其高度敏感。在治疗过程中,氟喹诺酮类药物需每日给药两次,持续5天,因此需要重复给药。环丙沙星符合控释给药系统候选药物的条件。

目的

本研究旨在通过湿法制粒法制备含盐酸环丙沙星的骨架片。

材料与方法

以乙基纤维素100 Premium和优特奇®RS PO(赢创实验室,印度孟买)作为控速聚合物制备片剂。使用邻苯二甲酸二辛酯(DCP)颗粒作为稀释剂。采用异丙醇和二氯甲烷(1:1)的混合物作为制粒剂。基于重量差异、硬度、脆碎度、厚度和药物释放曲线,考察了处方变量对片剂性能的影响。结果表明片剂具有良好的完整性。

结果

片剂在18个月内稳定。处方F7在12小时内呈现线性释放模式。F7处方中环丙沙星的释放符合零级动力学。由于符合Higuchi方程,发现释放机制为扩散控制。

结论

成功制备了含盐酸环丙沙星的骨架片。片剂具有良好的完整性,在18个月内稳定。

相似文献

1
Formulation and evaluation of controlled-release matrix systems of ciprofloxacin.环丙沙星控释基质系统的制剂与评价
Polim Med. 2017 Jul-Dec;47(2):101-106. doi: 10.17219/pim/90020.
2
In vitro quality evaluation of leading brands of ciprofloxacin tablets available in Bangladesh.孟加拉国市场上主要品牌环丙沙星片剂的体外质量评估。
BMC Res Notes. 2017 May 30;10(1):185. doi: 10.1186/s13104-017-2507-y.
3
Evaluation of Eudragit RS-PO and Ethocel 100 matrices for the controlled release of lobenzarit disodium.评价用于苯磺酰吡酸二钠控释的Eudragit RS-PO和乙基纤维素100基质。
Drug Dev Ind Pharm. 1999 Feb;25(2):229-33. doi: 10.1081/ddc-100102164.
4
Eudragit NE30D based metformin/gliclazide extended release tablets: formulation, characterisation and in vitro release studies.基于Eudragit NE30D的二甲双胍/格列齐特缓释片:制剂、表征及体外释放研究
Chem Pharm Bull (Tokyo). 2002 Nov;50(11):1495-8. doi: 10.1248/cpb.50.1495.
5
Eudragit(®) RS PO/RL PO as rate-controlling matrix-formers via roller compaction: Influence of formulation and process variables on functional attributes of granules and tablets.Eudragit(®) RS PO/RL PO 作为控释骨架材料的制粒:配方和工艺变量对颗粒和片剂功能特性的影响。
Drug Dev Ind Pharm. 2012 Oct;38(10):1240-53. doi: 10.3109/03639045.2011.645831. Epub 2012 Jan 19.
6
The development and in vitro evaluation of sustained release tablet formulations of benzydamine hydrochloride and its determination.盐酸苄达明缓释片制剂的研制、体外评价及其含量测定
Comb Chem High Throughput Screen. 2010 Sep;13(8):683-9. doi: 10.2174/138620710791920347.
7
Eudragit-S, Eudragit-L and cellulose acetate phthalate coated polysaccharide tablets for colonic targeted delivery of azathioprine.Eudragit-S、Eudragit-L 和醋酸纤维素酞酸酯包衣多糖片用于柳氮磺胺吡啶结肠定位释放。
Pharm Dev Technol. 2010 Jul-Aug;15(4):431-7. doi: 10.3109/10837450903264401.
8
The effect of processing variables on the mechanical and release properties of tramadol matrix tablets incorporating Cissus populnea gum as controlled release excipient.加工变量对以洋常春藤胶为控释辅料的曲马多基质片的机械性能和释放特性的影响。
Polim Med. 2014 Oct-Dec;44(4):209-20.
9
The effect of tablet formulation and hardness on in vitro release of cephalexin from Eudragit L100 based extended release tablets.片剂配方和硬度对基于Eudragit L100的头孢氨苄缓释片体外释放的影响。
Biol Pharm Bull. 2002 Apr;25(4):541-5. doi: 10.1248/bpb.25.541.
10
Citric acid monohydrate as a release-modifying agent in melt extruded matrix tablets.柠檬酸一水合物作为熔融挤出型骨架片中的释放调节剂。
Int J Pharm. 2008 Sep 1;361(1-2):158-68. doi: 10.1016/j.ijpharm.2008.05.035. Epub 2008 Jun 5.